Novo Nordisk A/S (NVO)

45.18
NYSE : Health Care
Prev Close 45.34
Day Low/High 45.08 / 45.30
52 Wk Low/High 30.89 / 47.98
Avg Volume 1.86M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 115.62B
EPS 2.00
Div & Yield 0.95 (2.10%)

Latest News

IIROC Trading Halt - NVO

IIROC Trading Halt - NVO

Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade

Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade

World's biggest diabetes drugmaker sees lower 2018 prices in U.S. markets

IIROC Trading Resumption - NVO

IIROC Trading Resumption - NVO

Novo Provides Corporate Update

Novo Provides Corporate Update

Novo Reports No Material Change

Novo Reports No Material Change

IIROC Trading Resumption - NVO

IIROC Trading Resumption - NVO

IIROC Trading Halt - NVO

IIROC Trading Halt - NVO

Looking for Some Positive Spin

Breadth and volume should've been better.

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices

The legislation would also force companies to announce planned price hikes.

Dow Holds Lower After House Passes Health Care Vote, Crude Falls

Dow Holds Lower After House Passes Health Care Vote, Crude Falls

Stocks move mostly lower on Thursday after the House passes a bill to repeal and replace the Affordable Care Act.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, DVN, EXEL, FMC, FSI, GLT, MEOH, MJCO, MOH, NVO, RPXC, TECH, WU, WWE Downgrades: CIGI, IPHI, QUOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Novo Nordisk Launches Xultophy® 100/3.6 (insulin Degludec And Liraglutide Injection) In The United States

- New combination treatment option for adults with type 2 diabetes now available in pharmacies

Daily Earnings Round-Up

Daily Earnings Round-Up

This is your round-up of the day's earnings reports

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures decline and European shares trade lower following disappointing earnings from Apple and as Wall Street looks to Wednesday's announcement from the Federal Reserve on interest rates.